Emergent Biosolutions EBS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's software and technology licenses, net?
- Emergent Biosolutions (EBS) reported software and technology licenses, net of $13M in Q1 2026.
- How has Emergent Biosolutions's software and technology licenses, net changed year-over-year?
- Emergent Biosolutions's software and technology licenses, net decreased by 0.8% year-over-year, from $13.1M to $13M.
- What is the long-term trend for Emergent Biosolutions's software and technology licenses, net?
- Over 5 years (2020 to 2025), Emergent Biosolutions's software and technology licenses, net has grown at a -34.0% compound annual growth rate (CAGR), from $113.4M to $14.2M.